» Articles » PMID: 38002949

The Novel Link Between Gene Expression Profiles of Adult T-Cell Leukemia/Lymphoma Patients' Peripheral Blood Lymphocytes and Ferroptosis Susceptibility

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2023 Nov 25
PMID 38002949
Authors
Affiliations
Soon will be listed here.
Abstract

Ferroptosis, a regulated cell death dependent on iron, has garnered attention as a potential broad-spectrum anticancer approach in leukemia research. However, there has been limited ferroptosis research on ATL, an aggressive T-cell malignancy caused by HTLV-1 infection. Our study employs bioinformatic analysis, utilizing dataset GSE33615, to identify 46 ferroptosis-related DEGs and 26 autophagy-related DEGs in ATL cells. These DEGs are associated with various cellular responses, chemical stress, and iron-related pathways. Autophagy-related DEGs are linked to autophagy, apoptosis, NOD-like receptor signaling, TNF signaling, and the insulin resistance pathway. PPI network analysis revealed 10 hub genes and related biomolecules. Moreover, we predicted crucial miRNAs, transcription factors, and potential pharmacological compounds. We also screened the top 20 medications based on upregulated DEGs. In summary, our study establishes an innovative link between ATL treatment and ferroptosis, offering promising avenues for novel therapeutic strategies in ATL.

Citing Articles

Key candidate genes and pathways in T lymphoblastic leukemia/lymphoma identified by bioinformatics and serological analyses.

Ren Y, Liang H, Huang Y, Miao Y, Li R, Qiang J Front Immunol. 2024; 15:1341255.

PMID: 38464517 PMC: 10920334. DOI: 10.3389/fimmu.2024.1341255.

References
1.
Yu Y, Xie Y, Cao L, Yang L, Yang M, Lotze M . The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol Cell Oncol. 2016; 2(4):e1054549. PMC: 4905356. DOI: 10.1080/23723556.2015.1054549. View

2.
Lee J, Roh J . Unleashing Ferroptosis in Human Cancers: Targeting Ferroptosis Suppressor Protein 1 for Overcoming Therapy Resistance. Antioxidants (Basel). 2023; 12(6). PMC: 10295722. DOI: 10.3390/antiox12061218. View

3.
Izutsu K, Makita S, Nosaka K, Yoshimitsu M, Utsunomiya A, Kusumoto S . An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma. Blood. 2022; 141(10):1159-1168. PMC: 10651775. DOI: 10.1182/blood.2022016862. View

4.
Van Damme J, De Ley M, Opdenakker G, Billiau A, DE SOMER P, Van Beeumen J . Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1. Nature. 1985; 314(6008):266-8. DOI: 10.1038/314266a0. View

5.
Xia J, Lyle N, Mayer M, Pena O, Hancock R . INVEX--a web-based tool for integrative visualization of expression data. Bioinformatics. 2013; 29(24):3232-4. PMC: 3842763. DOI: 10.1093/bioinformatics/btt562. View